During the past decade, Associated Retinal Consultants, PC conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 8 clinical trials were completed, i.e. on average, 29.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associated Retinal Consultants, PC" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Aura Biosciences" with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Kodiak Sciences Inc" with 4 trials sponsored and "ThromboGenics" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associated Retinal Consultants, PC" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Mid Atlantic Retina" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Associated Retinal Consultants, PC" are "Geographic Atrophy" (5 trials), "Macular Edema" (5 trials), "Choroidal Melanoma" (4 trials), "Macular Degeneration" (4 trials) and "Diabetic Macular Edema" (3 trials). Many other conditions were trialed in "Associated Retinal Consultants, PC" in a lesser frequency.

Most popular intervention types in "Associated Retinal Consultants, PC" are "Drug" (33 trials), "Other" (10 trials), "Procedure" (5 trials), "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (8 trials), "Sham Procedure" (8 trials), "Faricimab" (4 trials), "KSI-301" (4 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Associated Retinal Consultants, PC" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Associated Retinal Consultants, PC". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Associated Retinal Consultants, PC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Associated Retinal Consultants, PC, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".